The objective of this study was to assess the 48-week virological efficacy of atazanavir/ritonavir ( ATV/r ) monotherapy vs. ATV/r along with two nucleoside reverse transcriptase ( NRTIs ) in HIV-1 treated individuals with HIV-RNA less than 50copies/ml .